Etiology, Prognosis, and Hemostatic Function after Cerebral Infarction in Young Adults
Stroke 20:477-482, Chancellor,A.M.,et al, 1989
Cerebrovascular Disease & Antiphospholipis Antibodies in SLE, Lupus-Like Dis, & Primary Antiphospholipid Synd
Am J Med 86:391-399, Asherson,R.A.,et al, 1989
Cardiogenic Brain Embolism and Lupus Anticoagulants
Ann Neurol 26:390-392, Young,S.M.,et al, 1989
Antiphospholipid Antibodies
Ann Neurol 26:386-389, Levine,S.R.&Welch,K.M.A., 1989
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Lupus Anticoagulants, Anticardiolipin Antibodies, and Cerebral Ischemia
Stroke 20:225-229, Kushner,M.&Simonian,N., 1989
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Amaurosis Fugax Associated with Antiphospholipid Antibodies
Ann Neurol 25:228-232, Digre,K.B.,et al, 1989
Antiphospholipid Antibodies:A Risk Facor for Occlusive Ocular Vascular Disease in Systemic Lupus Erythematosus and the 'Primary' Antiphospholipid Syndrome
Ann Rheumatic Dis 48:358-361, Asherson,R.A.,et al, 1989
Clinicopath Conf
Antiphospholipid-Antibody Syndrome, ANA-Negative Systemic Lupus Erythematosus, Case Study 37-1988, N, JM :699-712,1988., 1988
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987
Multiple Cerebral Infarctions & Dementia Associated with Anticardiolipin Antibodies
Stroke 18:1107-1112, Coull,B.M.,et al, 1987
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
Cerebral Venous Thrombosis with Lupus Anticoagulants, Report of Two Cases
Stroke 18:801-804, Levine,S.R.,et al, 1987
Recurrent Stroke Associated with Thymoma & Anticardiolipin Antibodies
Arch Neurol 44:678-679, Levine,S.R.,et al, 1987
Cerebral Infarct, TIA, & Lupus Inhibitor
Neurol 36:1234-1237, Fisher,M.&McGehee,W., 1986
Recurrent Cerebral Infarctions in Two Brothers with Antiphospholipid Antibodies that Block Coagulation Reactions
Stroke 17:98-102, Jacobson,D.M.,et al, 1986
Association of Lupuslike Anticoagulant & Nonvasculitic Cerebral Infarction
Arch Neurol 43:851-852, Tabachnik-Schor,N.F.&Lipton,S.A., 1986
Cerebral Ischemia in the Presence of Lupus Anticoagulant
Arch Neurol 41:521-523, Kelley,R.E.,et al, 1984
Acute Subdural Hematomas with Lupus Anticoagulant (Procoagulant inhibitor)
Neurol 34:519-521, Feit,H.,et al, 1984
Degos'Disease:Association with Anticardiolipin Antibodies & the Lupus Anticoagulant
BMJ 289:576, Englert,H.J.,et al, 1984
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice
Neurol 104:e213498, Zara,P.,et al, 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology
Ann Neurol 96:1020-1025, Falso,S.,et al, 2024
Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024
Recurrent Rhombencephalitis Associatedwith Anti-GAD65 Antibody
Neurol 102:e208040, Alferes,A.R.,et al, 2024
Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024
Clinicopatholigical Conference, Plasmodium Falciparum Malaria
NEJM 309:549-556, Case 4-2024, 2024
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Clinicopathologic Conference, Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis
NEJM 390:843-851, Case 7-2024, 2024
Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024
Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024
Neurocysticercosis School Outbreak in Belgium
Lancet 404:2415-2416, Vanden Driessche,K., et al, 2024
Clinical Reasoning: A 39-Year-Old Returning traveler with Acute Encephalopathy and Strokes
Neurol 104:e210177, Buback,ClT.,et al, 2024
Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024
MOG-IgG-Associated Encephalitis with FLAIR Hyperintensity Along the Brainstem Surface
Ann Neurol 96:460-462, Yin,J.,et al, 2024
Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024
Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children
Neurol 103:e209321, Varley,J.A.,et al, 2024
Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024
MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis:A Systematic Review and Meta-Analysis
AJNR 45:977-986, Almeida,F.C.,et al, 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024
Diffusely Enhancing Lesions on MRI in DPPX Antibody-Associated Encephalitis
JAMA Neurol 8:418-419, Liu,M.,et al, 2024